Milano Cord Blood Bank, Centre of Transfusion Medicine, Cellular Therapy and Cryobiology, Department of Regenerative Medicine, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Cell Prolif. 2011 Apr;44 Suppl 1(Suppl 1):30-4. doi: 10.1111/j.1365-2184.2010.00720.x.
On 31 May 2010, 14 072 567 bone marrow/apheresis donors registered in 44 countries and 426 501 cord blood units banked in 26 countries for public use were available to treat candidates to haemopoietic stem cell transplant lacking a family related compatible donor. Despite these impressive numbers, additional efforts are required to ensure that all patients, including those from ethnic minorities, can promptly find a suitable donor. Governments, clinicians, scientists, patients and stakeholders should share the responsibility to develop haemopoietic stem cell donation and cord blood banking models able to fully match all patient needs. In this regard, current scientific evidence and prevalent opinions among expert clinicians support solidaristic cord blood donation for public use against the alternative option of commercial autologous cord blood storage.
2010 年 5 月 31 日，44 个国家共有 14072567 名骨髓/外周血捐献者注册，26 个国家的 426501 个脐带血单位可供公共使用，用于治疗缺乏家族相关相容供体的造血干细胞移植候选者。尽管这些数字令人印象深刻，但仍需做出更多努力，以确保所有患者，包括少数民族患者，都能迅速找到合适的供体。政府、临床医生、科学家、患者和利益相关者都应共同承担发展造血干细胞捐献和脐带血库的责任，以充分满足所有患者的需求。在这方面，当前的科学证据和专家临床医生的普遍观点支持将脐带血用于公共用途的团结性捐献，而不是将商业性自体脐带血储存作为替代选择。
